241 related articles for article (PubMed ID: 27873431)
1. Hypoglycemia is common in children with cystic fibrosis and seen predominantly in females.
Haliloglu B; Gokdemir Y; Atay Z; Abali S; Guran T; Karakoc F; Ersu R; Karadag B; Turan S; Bereket A
Pediatr Diabetes; 2017 Nov; 18(7):607-613. PubMed ID: 27873431
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.
Kilberg MJ; Harris C; Sheikh S; Stefanovski D; Cuchel M; Kubrak C; Hadjiliadis D; Rubenstein RC; Rickels MR; Kelly A
J Clin Endocrinol Metab; 2020 Oct; 105(10):3179-89. PubMed ID: 32668452
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemia in children and young adults with cystic fibrosis during oral glucose tolerance testing vs. continuous glucose monitoring.
Finn E; Severn C; Pyle L; Garrish J; Vigers T; Behn CGD; Zeitler PS; Sagel SD; Nadeau KJ; Chan CL
Pediatr Pulmonol; 2023 Sep; 58(9):2495-2504. PubMed ID: 37350354
[TBL] [Abstract][Full Text] [Related]
4. Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.
Leclercq A; Gauthier B; Rosner V; Weiss L; Moreau F; Constantinescu AA; Kessler R; Kessler L
J Cyst Fibros; 2014 Jul; 13(4):478-84. PubMed ID: 24359972
[TBL] [Abstract][Full Text] [Related]
5. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
[TBL] [Abstract][Full Text] [Related]
6. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
[TBL] [Abstract][Full Text] [Related]
7. Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.
Prentice BJ; Chelliah A; Ooi CY; Hameed S; Verge CF; Plush L; Widger J
J Cyst Fibros; 2020 Mar; 19(2):305-309. PubMed ID: 31126898
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycemia in cystic fibrosis during an extended oral glucose tolerance test.
Armaghanian N; Hetherington J; Parameswaran V; Chua EL; Markovic TP; Brand-Miller J; Steinbeck K
Pediatr Pulmonol; 2020 Dec; 55(12):3391-3399. PubMed ID: 32955169
[TBL] [Abstract][Full Text] [Related]
9. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
[TBL] [Abstract][Full Text] [Related]
10. Can continuous glucose monitoring predict cystic fibrosis-related diabetes and worse clinical outcome?
Zorron M; Marson FAL; Morcillo AM; Gonçalves AC; El Beck MS; Ribeiro JD; Ribeiro AF
J Bras Pneumol; 2022; 48(2):e20210307. PubMed ID: 35475864
[TBL] [Abstract][Full Text] [Related]
11. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
[TBL] [Abstract][Full Text] [Related]
12. Relationship between exercise capacity and glucose tolerance in cystic fibrosis.
Foster K; Huang G; Zhang N; Crisalli J; Chini B; Amin R; Elder D
Pediatr Pulmonol; 2018 Feb; 53(2):154-161. PubMed ID: 29115018
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous hypoglycemia in patients with cystic fibrosis.
Battezzati A; Battezzati PM; Costantini D; Seia M; Zazzeron L; Russo MC; Daccò V; Bertoli S; Crosignani A; Colombo C
Eur J Endocrinol; 2007 Mar; 156(3):369-76. PubMed ID: 17322497
[TBL] [Abstract][Full Text] [Related]
14. Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance.
Bizzarri C; Lucidi V; Ciampalini P; Bella S; Russo B; Cappa M
J Endocrinol Invest; 2006 Mar; 29(3):RC1-4. PubMed ID: 16682829
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring.
Oki Y; Ono M; Hyogo H; Ochi T; Munekage K; Nozaki Y; Hirose A; Masuda K; Mizuta H; Okamoto N; Saibara T
Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):797-805. PubMed ID: 29634665
[TBL] [Abstract][Full Text] [Related]
16. The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis.
Chan CL; Pyle L; Vigers T; Zeitler PS; Nadeau KJ
J Clin Endocrinol Metab; 2022 Jan; 107(2):e548-e560. PubMed ID: 34537845
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hypoglycemia during oral glucose tolerance testing in adults with cystic fibrosis and risk of developing cystic fibrosis-related diabetes.
Mannik LA; Chang KA; Annoh PQK; Sykes J; Gilmour J; Robert R; Stephenson AL
J Cyst Fibros; 2018 Jul; 17(4):536-541. PubMed ID: 29680365
[TBL] [Abstract][Full Text] [Related]
18. Postprandial hyperglycemia and pancreatic function in cystic fibrosis patients.
Hinds A; Sheehan AG; Machida H; Parsons HG
Diabetes Res; 1991 Oct; 18(2):69-78. PubMed ID: 1841815
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
[TBL] [Abstract][Full Text] [Related]
20. Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.
Taylor-Cousar JL; Janssen JS; Wilson A; Clair CG; Pickard KM; Jones MC; Brayshaw SJ; Chacon CS; Barboa CM; Sontag MK; Accurso FJ; Nichols DP; Saavedra MT; Nick JA
J Diabetes Res; 2016; 2016():1527932. PubMed ID: 27999822
[No Abstract] [Full Text] [Related]
[Next] [New Search]
